Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A
- PMID: 19242551
- PMCID: PMC2645681
- DOI: 10.1371/journal.pone.0004606
Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A
Abstract
Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis. They present also learning impairments modeling those encountered in Down syndrome. Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions. Gene dosage correction induces a rescue of the brain volume alterations. DYRK1A is also involved in the control of synaptic plasticity and memory consolidation. Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice. Epigallocatechin gallate (EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor. We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood. The major features of the transgenic phenotype were rescued in these mice.
Conflict of interest statement
Figures





Similar articles
-
Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins.Int J Mol Sci. 2020 Feb 19;21(4):1404. doi: 10.3390/ijms21041404. Int J Mol Sci. 2020. PMID: 32092951 Free PMC article.
-
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.Physiol Behav. 2017 Aug 1;177:230-241. doi: 10.1016/j.physbeh.2017.05.003. Epub 2017 May 3. Physiol Behav. 2017. PMID: 28478033 Free PMC article.
-
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.Neurobiol Dis. 2020 May;138:104791. doi: 10.1016/j.nbd.2020.104791. Epub 2020 Feb 4. Neurobiol Dis. 2020. PMID: 32032735 Free PMC article.
-
Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.Biol Chem. 2002 Jan;383(1):101-5. doi: 10.1515/BC.2002.010. Biol Chem. 2002. PMID: 11928805 Review.
-
Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.Forum Nutr. 2009;61:156-169. doi: 10.1159/000212748. Epub 2009 Apr 7. Forum Nutr. 2009. PMID: 19367120 Review.
Cited by
-
New insights into the regulation of Cystathionine beta synthase (CBS), an enzyme involved in intellectual deficiency in Down syndrome.Front Neurosci. 2023 Jan 9;16:1110163. doi: 10.3389/fnins.2022.1110163. eCollection 2022. Front Neurosci. 2023. PMID: 36711154 Free PMC article.
-
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse.Antioxidants (Basel). 2019 Jun 6;8(6):163. doi: 10.3390/antiox8060163. Antioxidants (Basel). 2019. PMID: 31174258 Free PMC article.
-
Molecular rescue of DYRK1A overexpression in cystathionine beta synthase-deficient mouse brain by enriched environment combined with voluntary exercise.J Mol Neurosci. 2015 Feb;55(2):318-23. doi: 10.1007/s12031-014-0324-5. Epub 2014 May 13. J Mol Neurosci. 2015. PMID: 24819931
-
Network Pharmacology Identifies Intersection Genes of Apigenin and Naringenin in Down Syndrome as Potential Therapeutic Targets.Pharmaceuticals (Basel). 2024 Aug 20;17(8):1090. doi: 10.3390/ph17081090. Pharmaceuticals (Basel). 2024. PMID: 39204195 Free PMC article.
-
Multimodal in vivo Imaging of the Integrated Postnatal Development of Brain and Skull and Its Co-modulation With Neurodevelopment in a Down Syndrome Mouse Model.Front Med (Lausanne). 2022 Feb 11;9:815739. doi: 10.3389/fmed.2022.815739. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35223915 Free PMC article.
References
-
- Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1(2):114–24. - PubMed
-
- Korenberg JR, Aaltonen J, Brahe C, Cabin D, Creau N, et al. Report and abstracts of the Sixth International Workshop on Human Chromosome 21 Mapping. Cold Spring Harbor, New York, USA. May 6–8,1996. Cytogenet Cell Genet. 1997;79(1–2):21–52. - PubMed
-
- Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet. 1996;Sep;5(9):1305–10. - PubMed
-
- Tejedor F, Zhu XR, Kaltenbach E, Ackermann A, Baumann A, et al. Minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron. 1995;Feb;14(2):287–301. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical